These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 625941)

  • 1. [Effect of complamine on various indicators of hemostasis and microcirculation in chronic ischemic heart disease].
    Bol'shakova RM; Dukhina MA; Furkalo NK; Solovtsova KM; Progonnaia VV
    Vrach Delo; 1978 Jan; (1):36-40. PubMed ID: 625941
    [No Abstract]   [Full Text] [Related]  

  • 2. [Therapeutic effect of complamine in atherosclerosis and ischemic heart disease].
    Kalmykova VI; Aronchuk EK
    Sov Med; 1976 Jan; (1):113-8. PubMed ID: 1273633
    [No Abstract]   [Full Text] [Related]  

  • 3. [Treatment of ischemic heart disease with complamine].
    Kuz'ko NV
    Vrach Delo; 1981 Jan; (1):82-4. PubMed ID: 7010784
    [No Abstract]   [Full Text] [Related]  

  • 4. [Use of komplamin in chronic ischemic heart disease].
    Serkova VK; Mikunis RI
    Vrach Delo; 1984 Nov; (11):16-8. PubMed ID: 6528554
    [No Abstract]   [Full Text] [Related]  

  • 5. [Effect of fenicaberan and xavin on peripheral hemodynamic and blood coagulability indices in patients with chronic ischemic heart disease].
    Shpak BIu; Neĭko EM; Debenklo MV; Lazho AS; Duma ZV
    Vrach Delo; 1988 Mar; (3):34-6. PubMed ID: 3394293
    [No Abstract]   [Full Text] [Related]  

  • 6. [Ergometric evaluation of treatment of ischemic heart disease with xavine].
    Zadionchenko VS; Vertkin AL; Martynov AI; Panchenkova LA; Troshina EV
    Sov Med; 1978 Jan; (1):68-73. PubMed ID: 635674
    [No Abstract]   [Full Text] [Related]  

  • 7. [Use of xanthinol nicotinate in patients with chronic ischemic heart disease].
    Sivkov II; Kukes VG; Borisov VG; Rudakov MA; Blistanova LS
    Ter Arkh; 1977; 49(1):30-3. PubMed ID: 867235
    [No Abstract]   [Full Text] [Related]  

  • 8. [Use of trental and complamine in the microcirculatory disorders of diabetes mellitus].
    Spesivtseva VG; Kasabian IN; Mamaeva GG; Kukes VG
    Sov Med; 1980; (2):64-9. PubMed ID: 6987747
    [No Abstract]   [Full Text] [Related]  

  • 9. [Microcirculation disorders and their correction in patients with acute pancreatitis].
    Petrushova LD
    Vrach Delo; 1983 Feb; (2):19-20. PubMed ID: 6845690
    [No Abstract]   [Full Text] [Related]  

  • 10. [Effect of complamin and prodectin on microcirculation and lipid metabolism in psoriasis patients].
    Rakhmatov AB; Bilash NV
    Vestn Dermatol Venerol; 1983 Apr; (4):15-8. PubMed ID: 6868813
    [No Abstract]   [Full Text] [Related]  

  • 11. [Complamine in combination with methionine in the treatment of parapsoriasis].
    Orazymbetova ZhA
    Vestn Dermatol Venerol; 1978 Mar; (3):65-8. PubMed ID: 654516
    [No Abstract]   [Full Text] [Related]  

  • 12. [Surgical treatment of patients with rectal cancer taking into account microcirculation disorders].
    Kostia PI; Starikov VI; Voznitsin BB
    Klin Khir (1962); 1983 May; (5):22-4. PubMed ID: 6876577
    [No Abstract]   [Full Text] [Related]  

  • 13. [Comparative effectiveness of the local use of sodium nitrite, platyphylline and complamine in treating optic atrophy].
    Shpak NI; Salenko SV
    Oftalmol Zh; 1984; (5):294-7. PubMed ID: 6504461
    [No Abstract]   [Full Text] [Related]  

  • 14. [Evaluation of the efficacy of xavin treatment of ischemic heart disease].
    Pomerantsev VP; Ivanova NA; Zadionchenko VS; Vertkin AL; Martynov AI
    Kardiologiia; 1978 Mar; 18(3):36-43. PubMed ID: 347136
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Treatment of chronic arterial vascular disorders with Complamin and Complamin retard].
    Musil HE
    Med Welt; 1973 Jan; 24(3):103-13. PubMed ID: 4617835
    [No Abstract]   [Full Text] [Related]  

  • 16. [Rehabilitation course in patients with peripheral and coronary angio-organopathies. Studies with special reference to serum uric acid and cholesterol under xanthinol nicotinate].
    Mensen H
    Ther Ggw; 1977 Oct; 116(10):1853-81. PubMed ID: 918880
    [No Abstract]   [Full Text] [Related]  

  • 17. [Results of a long-term study on the therapeutic effectiveness of xanthinol nicotinate in chronic hepatopathies].
    Dohrmann RE; Kessel ME
    Z Allgemeinmed; 1975 Sep; (26):1167-72. PubMed ID: 1226797
    [No Abstract]   [Full Text] [Related]  

  • 18. [Effect of nitroglycerin-retard on central and peripheral hemodynamics, microcirculation and hemostasis].
    Solov'eva FV; Kirichenko LL; Smirnov VV; Kurakina TI; Shchadrintseva MI
    Sov Med; 1987; (8):3-5. PubMed ID: 3122332
    [No Abstract]   [Full Text] [Related]  

  • 19. [Use of complamin in nephrological practice].
    Mamikonian RS; Barsegian BA; Tumanian AM; Arutiunian VM; Basmadzhian NM
    Zh Eksp Klin Med; 1979; 19(4):62-7. PubMed ID: 506579
    [No Abstract]   [Full Text] [Related]  

  • 20. [Prolonged clinical study of the LA, 313-B-xanthinol niacinate pentosan sulfonate ester combination in various forms of hypertension].
    Masso M; Gimeno Martínez J; Honorato J
    Rev Clin Esp; 1976 Jul; 142(2):157-61. PubMed ID: 968103
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.